CRYSTALLINE SALT OF NINTEDANIB DIETHANESULFONATE AND METHOD FOR PRODUCTION AND USE THEREOF Russian patent published in 2019 - IPC C07D209/34 A61K31/496 A61P11/00 A61P35/00 A61P37/00 

Abstract RU 2708683 C2

FIELD: chemistry.

SUBSTANCE: present invention relates to crystalline salt of nintedanib diethanesulfonate of A-type represented by formula (II), and also relates to a crystalline composition and a pharmaceutical composition containing a crystal, and to a method for production and use thereof. X-ray powder diffractometry spectrum of the crystalline nintedanib salt of diethanesulfonate of the present invention is characterized by diffraction peaks at approximately 14.64, 18.79, 19.31, 20.11, 21.20, 22.45 and 26.71°, if presented in values 2θ.

EFFECT: crystalline nintedanib diethanesulfonate salt of the present invention is characterized by resistance, is non-hygroscopic and difficult to decompose, and is most suitable for medical production.

18 cl, 2 dwg, 3 tbl, 4 ex

Similar patents RU2708683C2

Title Year Author Number
CRYSTALLINE FORMS OF THE DIHYDROPYRIMIDIN DERIVATIVES 2013
  • Chzhan Inzhun
  • Zhen Tsinguan
  • Lyu Sinchan
  • Van Chaolej
  • Van Tyanmin
  • Goldmann Zigfrid
RU2646599C2
POLYMORPHOUS AND AMORPHOUS FORMS OF {2-FLUORINE-5-[3-((E)-2-PYRIDINE-2-ILVINYL)-1N-INDAZOLE-6-ILAMINE]PHENYL}AMIDE 2, 5-DIMETHYL-2N-PYRAZOLE-3-CARBONIC ACID 2005
  • E Tsjan'
  • Zuk Skott Ehdvard
  • Oullet Majkl Allen
  • Khettinger Donald Nikolas
  • Srirangam Dzhajaram Kasturi
  • Kanija Robert Stiven
  • Saeed Nabil' Lauze
  • Uajtlin Mehtt'Ju Dehvid
  • Mitchell Mark Brajan
RU2324692C1
CRYSTALLINE OR AMORPHOUS FORM OF FXR AGONISTS BEING STEROID DERIVATIVES, THEIR PRODUCTION METHOD AND THEIR USE 2018
  • Li, Syaolin
  • Syao, Khualin
  • Li, Pen
  • Khe, Khajin
  • Li, Vejdun
RU2800751C2
CRYSTALLINE FORM OF SODIUM SALT OF 4-TERT-BUTYL-N-[4-CHLORO-2-(1-OXY-PYRIDINE-4-CARBONYL)-PHENYL]-BENZENESULFONAMIDE 2012
  • Pennell Andreu M.K.
  • Ungashe Solomon
RU2607515C2
SYK INHIBITOR SALT AND CRYSTALLINE FORM THEREOF 2019
  • Tsyan, Venyuan
  • Van, Khuntszyan
  • Chzhan, Min
  • Lyu, Fej
  • Sin, Lej
  • Khu, Chzhunyuan
  • Go, Yakhuej
  • Lyu, Yanlun
  • Chzhan, Khuejkhuej
RU2818103C2
LONG-ACTING DPP-IV INHIBITOR CRYSTAL AND ITS SALTS 2017
  • Sang Guangming
  • Liu Lin
  • Zhang Aiming
  • Qiao Jiabin
  • Guo Xiaopeng
  • Zhang Xiquan
  • Xia Chunguang
RU2753335C2
MULTICOMPONENT CRYSTALS COMPRISING DASATINIB AND SELECTED COCRYSTAL FORMERS 2013
  • Chiodo Titsiana
  • Khafner Andreas
  • Khintermann Tobias
  • Zalvador Beate
  • Shelagevich Martin
  • Blatter Fritts
  • Zibenkhaar Bernd
  • Fossen Markus
RU2650524C2
SALT OF MU-OPIOID RECEPTOR (MOR) AGONIST, CRYSTAL FORM I OF ITS FUMARATE SALT, AND THEIR PRODUCTION METHOD 2018
  • Wang, Lin
  • Wang, Likun
RU2779119C2
POLYMORPHIC FORMS OF SODIUM SALT OF 4-TERT-BUTYL-N-[4-CHLORO-2-(1-OXY-PYRIDINE-4-CARBONYL)-PHENYL]-BENZENESULPHONAMIDE 2012
  • Bis Dzhoanna
  • Igo David Kh.
RU2607191C2
STABLE CRYSTALLINE FORM OF 2-ETHYL-3,7-DIMETHYL-6-(4-TRIFLUOROMETHOXY)PHENOXY)QUINOLIN-4-YLMETHYLCARBONATE, METHOD OF OBTAINING THEREOF AND AGROCHEMICAL COMPOSITION, CONTAINING SAID CRYSTALLINE FORM 2011
  • Tanigakiuti Kouki
  • Sekiguti Mikio
  • Khotta Khiroki
  • Simano Sidzuo
  • Morikava Akinori
  • Jamamoto Kadzumi
  • Nakanisi Nodzomu
  • Minova Nobuto
  • Vatanabe Takasi
RU2545094C2

RU 2 708 683 C2

Authors

Wang Hubo

Zhu Xueyan

Guo Meng

Hu Mingtong

Zhang Jiasong

Sun Jiude

Dates

2019-12-11Published

2016-03-11Filed